Real-World Effectiveness and Risk Factors for Discontinuation of Ustekinumab in Ulcerative Colitis
{{output}}
Introduction: Ustekinumab (UST) has been approved for the treatment of moderate-to-severe ulcerative colitis (UC). Real-world data showing the effectiveness and safety of UST are necessary to confirm the results of clinical trial... ...
